In vitro test of a potential hypoxic radiosensitizer by Mei, Yaowen
 In vitro test of a potential hypoxic 
radiosensitizer 
by 
Yaowen Mei 
 
 
 
A thesis 
presented to the University of Waterloo 
in fulfilment of the  
thesis requirement for the degree of 
Master of Science 
in 
Physics 
 
 
Waterloo, Ontario, Canada, 2016 
© Yaowen Mei 2016 
 
 ii 
Author’s Declaration 
 
I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, 
including any required final revisions, as accepted by my examiners.  
I understand that my thesis may be made electronically available to the public 
.
 iii 
 
Abstract 
 
Oxygen has long been known as a potent radiosensitizer that can enhance the cell killing 
effects in aerobic cells, while pruned vasculatures and lack of oxygen in the 
microenvironment of tumor can cause resistance to radiotherapy of cancer. Paradoxically, 
hypoxia also provides an attractive therapeutic target as it only occurs in solid tumors; 
hypoxia-activated radiosensitizers may be designed and synthesized with therapeutic 
selectivity on tumor cells.         
 
Directed by our previous femotomedicine (FMD) mechanistic research, our group has 
recently discovered a FMD compound that can react with pre-solvated electron (epre−) to 
increase the radiosensitivity in tumor tissues but relatively spare normal tissues. In this thesis 
work, the in vitro selective radiosensitivity of the FMD compound against hypoxic cancer 
cells was evaluated through the steady-state absorption spectrum analysis, the 
immunofluorescence assay, and the clonogenic assay. The results demonstrated that the FMD 
compound is an effective radiosensitizer in the hypoxic environment (radio enhancement 
ratio =1.420.05 ), and the potency of the radiosensitizing effect of the FMD compound in 
the oxic (normal) environment will be limited due to the competing attachments of pre-
solvated electrons with the FMD molecules and molecular oxygens. The revealing of the 
underlying mechanism of the FMD compound’s radiosensitizing effect provides new insight 
into the design of novel hypoxia-activated radiosensitizers. 
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 1 
Chapter 1 Introduction 
 
 
1.1 Cancer and cancer therapy 
 
Cancer are the most challenging diseases in the world with high morbidity and mortality. In 
the year of 2016, more than 1.68 million people are projected to be diagnosed as cancer 
patients, and 595,690 people are estimated to be killed by cancer in the United States[1]. 
Based on a global survey from the World Health Organization in 2012[2], lung, prostate and 
colorectum were the three sites with the highest tendency to be diagnosed of cancer among 
men; meanwhile, among women, the three most common cancer incident sites were breasts, 
colorectum and lung. For both genders, lung, breasts and colorectum were the leading sites 
with the highest cancer incidence rates, at 12.9%, 11.9% and 9.7% of the total study 
population, respectively. They accounted for more than one third of the worldwide cancer 
burden[3]. 
 
From 2009 to 2016, more than ninety oncologic drugs were approved by the US Food and 
Drug Administration (FDA)[4]–[9]. With tremendous efforts of cancer researchers, several 
therapeutic methods for cancer have been established, such as 1) surgery, 2) radiotherapy, 3) 
chemotherapy, 4) photodynamic therapy (PDT), 5) hormones, etc. Surgery is the dominant 
choice of treatment after being diagnosed, and it is often combined with chemotherapy, 
radiotherapy, and photodynamic therapy. Radiotherapy, an alternative to surgery, is to use 
ionizing radiation to control or locally remove malignant cells. Generally, more than two 
 2 
thirds of cancer patients will receive radiotherapy as a part of their treatment plan[10]. 
Chemotherapy is to use cytotoxic and cytostatic agents to kill malignant cells. This treatment 
is largely used for palliative in the advanced tumors which cannot be readily treated by 
surgery and radiation. Among all these therapeutics, surgery and radiotherapy are the two 
dominant curative treatments for cancer[11], but all the therapeutics can be involved for 
palliation[12]. However, so far, only a few radiosensitizing agents have been eventually 
approved by the FDA. Therefore, effective radiosensitizer especially the one with 
selectivity that can spare normal tissue but remove the malignancy, should be a desired 
weapon in the battle against cancer. If it succeeds, these novel radiosensitizers will contribute 
considerably to human health and the lives of cancer patients. 
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1.2 Radiation therapy 
 
The objective of radiation therapy is to use high energy radiation to cure or control cancer, or 
to reduce cancer symptoms. The amount of energy released by a radiation flux over its unit 
track length is defined as linear energy transfer (LET): 
  , 
Eq. 1-1 
 
Where dE is the energy transferred to the medium by the radiation source while traversing a 
unit distance dx. For neutrons, α particles, and other heavy charged particles, as large amount 
of energy is deposited along the track, these types of radiations are called high linear energy 
transfer (High-LET) radiations. For radiations like X-Rays and γ-Rays, as less amount of 
energy is deposited per unit length and the ionizing events spread in wide spatial ranges, 
these kinds of radiation are called low linear energy transfer (Low-LET) radiations. 
 
As DNA regulates a cell’s activity and contains the information for a cell to replicate itself, 
damages to DNA will alter cell function and result in cell death. In radiation therapy, the 
most important target is the DNA in the cell. When the radiation-induced DNA damage 
cannot be repaired instantly or is improperly repaired, these DNA damages may lead to 
mutations, apoptosis, necrosis, and eventually the cell may lose the ability of proliferation. 
During ionizing radiation, there are two types of actions related to DNA damage will take 
place: direct and indirect action (see Figure 1-1). Direct action involves when the ionizing 
particle directly deposits its energy to ionize the genome; indirect action occurs when the 
LET=dE dx
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medium (predominantly water) absorbs most of the radiation energy and forms free radicals 
which produce further DNA damage[13]. By comparing the yield of γ-ray induced DNA 
strand breaks under aqueous and dry conditions at 25 , it was shown that for Low-LET 
radiation, indirect actions can produce several orders of magnitude more DNA damages than 
direct actions[14].  
 
 
Figure 1-1. The schematic diagram illustrating the direct action and the indirect action when DNA is 
exposed to ionizing radiation. In the direct action, the radiation energy is directly deposited to DNA 
to produce chemical bond breaks. In the indirect action, the majority of the radiation energy is 
absorbed by surrounding water molecules, and DNA damages are indirectly produced via free 
radicals and reactive molecules which are formed by water radiolysis. For Low-LET radiation (like x-
rays, and γ-rays), indirect action is predominant, and  produces more DNA damages than direct action. 
 
At the cellular level, the principal target for ionizing radiation (IR) is the cells’ DNA. 
However, radiation kills both normal cells and abnormal cancer cells along its track 
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(especially for Low-LET radiations). The most important challenge in radiation therapy is 
minimizing the radiation-induced damage to the adjacent health tissue while maximizing the 
radiation killing efficiency to the cancer cells[15]. The response of a tissue to radiation 
depends on the types of the irradiated cells, the microenvironment of the irradiated cells, and 
also different cell cycle phases the cells are in. The cells with high reproductive activity are 
more sensitive to radiation. Generally, the cells in the quiescent G0 or in the S phase show 
more resistance to radiation than the cells in M phase. The cells with high oxygen 
concentration are also more sensitive to radiation than the hypoxic tumor tissue (mechanism 
will be discussed in the following section). In radiation therapy, in order to minimize the 
damage to the adjacent and the overlying normal tissue and to reoxygenate the hypoxic tumor 
tissue, the radiation doses are often divided into many small fractions and given to patients 
over one to two months at a regular interval. Different fraction patterns, such as accelerated 
fractionation, hyper-fractionation and hypo-fractionation, are given to different patients 
depending on the severity and location of their tumors. Therefore, radiosensitizers, which can 
mimic the mechanism of oxygen and have natural selectivity that can sensitize the tumor 
tissue but spare the normal tissues and make the tumor to be cured by a large single dose 
instead of fraction doses, would greatly benefit the current concept of radiation therapy[16]. 
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1.3 Water radiolysis 
 
Radiation energy is absorbed by the components of the irradiated substance approximately 
proportionally to the mass of different components. When a cancer cell is irradiated, as cell is 
an aqueous system and water molecules make up to more than 70% of its cellular mass[17], 
water molecules will absorb most of the energy of the radiation flux. Consequently, the 
absorbed energy will lead to either excitation (Eq. 1-2) or ionization (Eq. 1-3) of these water 
molecules[18]: 
  Eq. 1-2 
  
Eq. 1-3 
 
For the excited water molecules, the majority of the them do not dissociate, but  just return 
back to the ground state (Eq. 1-4); while, only a small portion of them dissociate into 
hydrogen atoms and hydroxyl radicals (Eq. 1-5).  
  Eq. 1-4 
  Eq. 1-5 
 
For the ionized water molecules[19], the produced primary radical species are hydroxyl 
radicals, hydrogen atoms, and electrons (in both pre-solvated states and solvated states) (Eq. 
1-6). 
 
H2O 
Excitation⎯ →⎯⎯⎯ H2O
*
H2O 
Ionization⎯ →⎯⎯⎯ H2O
+ + e−
H2O
*⎯→⎯ H2O
H2O
*⎯→⎯ H• +HO•
 7 
  Eq. 1-6 
 
 
Eq. 1-7 
 
 
Eq. 1-8 
 
 
Figure 1-2. The time scale of events occurring in water radiolysis. Within 1 fs after irradiation, 
excited water molecules (H20*), ionized water molecules (H20+), and electrons (e-) are produced. 
Then, femto-chemistry reactions, such as ion-molecules reactions (Eq. 1-6), dissociative relaxations 
(Eq. 1-7), and solvation of electrons (Eq. 1-8), occurs in 10-15-10-12 s after irradiation. At ~10-6 s, 
radicals and reactive molecules diffuse in the solution and slow radical reactions produce indirect 
damages to a variety of cellular components. This figure is adapt from [20], [21]. 
 
In radiation chemistry, the yield of the altered entities is expressed by quantum yield, G value, 
which is a measurement of the number of formed (or destroyed) species per 100 eV energy 
absorbed by the entire sample: 
  Eq. 1-9 
H2O
+ + H2O ⎯→⎯ H3O
+ + HO•
H2O
+⎯→⎯ HO• +H+
e− + nH2O ⎯→⎯ ehyd
−
G(X) = number of species X formed energy absorbed in 100 eV
 8 
 
For the radiolysis of water, the quantum yields of the dissociation products are reported to be 
2.8, 2.4, 0.6 for the hydrated electrons (ehyd−), hydroxyl radicals (OH•), and hydrogen atoms 
(H•), respectively, at the microsecond time scale [18]–[22] (see Table 1-1).  The quantum 
yields of these water radiolysis products are multifactorial. The G-value can be influenced by 
the temperature, the PH value of the system, as well as the type of radiation. The LET of the 
radiation beam will change the ratio of excited water molecules over ionized water molecules; 
therefore, alter the yields of different radio-lytic species. The quantum yields of the radical 
products (OH•, epre−, and ehyd− ) decrease while the LET of the radiation increases. High-LET 
particles can also enhance the efficiency of the recombination of the radical products to form 
molecular species (H2O2 and H2)[23].   
 
It is commonly agreed that the hydrated electrons are trapped in a reduction potential well of 
about -3.5 eV and they have a significant long lifetime in pure water comparing with other 
radicals; therefore, they are inactive in producing biological damages. The hydroxyl radicals 
are used to be thought as the most important radical that can induce oxidative damage during 
IR. However, based on the femtosecond laser spectroscopy discovery, it was confirmed that 
the pre-solvated electrons were the principle culprits to be blamed for the IR induced 
biologically damages. 
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Water radiolysis products OH• epre− ehyd− H• H2O2 H2 
G-Value (#/100eV) 2.4 7.5 2.8 0.6 0.8 0.4 
Table 1-1. The quantum yields of the primary products from the radiolysis of liquid water. The 
fundamental role of epre−  played in radiation chemistry and biology was newly reported by our group 
based on our femtosecond time-resolved laser spectroscopy (fs-TRLS) measurement result[16], [24]–
[26]. These quantum yields depend on many parameters, such as PH, temperature, and the LET of the 
radiation. Different types of radiation will alter the ratio of excited H2O molecules over ionized H2O 
molecules, subsequently alter the quantum yield of each formed species. The G-value of epre− was 
estimated by considering 64% of the epre− eventually becomes the long-lived  ehyd−[21].  
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1.4 Pre-solvated electron 
 
The hydration dynamics of electrons in pure water has long been a mystery since the 
1960s[27]–[29]. With the pioneering work that was done by Ahmed H. Zewail and his co-
workers[30], [31], the development of the ultrafast time-resolved laser spectroscopy 
technique has paved the way for scientists to obtain a much deeper understanding of the 
fundamental mechanisms of electron hydration. It was found that prior to the electrons 
eventually solvated in liquid water, there exist finite-lifetime (< 1 picosecond ) precursor 
states called  pre-solvated electrons (epre−). In the year of 1987, the femtosecond time-scale 
lifetime of these pre-solvated electrons was first reported by Migus et al.[32]. After that, 
extensive follow up experiments have been conducted, but distinct physical proprieties and 
diverse ranges of lifetimes of epre− were reported. By carefully applying effective epre− 
scavengers, our lab demonstrated that there is a coherence spike in the current methodology 
of femtosecond time-resolved laser spectroscopy (fs-TRLS) measurement of epre−. This 
coherence spike affects the accuracy of the pre-solvated electrons’ lifetimes’ measurement, 
and the uncertainty that the spike brings to the pre-solvated electron’s  lifetime spanning over 
two orders of magnitude[26]. Our lab has found that the intensity of the coherence spike has 
a linear dependence to the pump power. By utilizing this property, one can subtract the 
coherence spike from the transient absorption measurement. After the removal of the 
coherence spike, the life time of epre− was determined precisely to be 540 ±  30 fs (as 
illustrated in Figure 1-3). 
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Figure 1-3. The schematic diagram illustrating the hydration dynamics of an electron in pure water. 
The per-solvated electron (epre−) is generated via two-photon excitation of water molecules, and then, 
within 540 fs, the epre−  solvates to the equilibrium state to form the so-called hydrated electron (ehyd−). 
The ehyd−  has a microsecond time-scale lifetime. Adapt from [26].  
 
The solvated electron is surrounded by water molecules. Theses polarized water molecules 
can form a deep reduction potential well. The solvated electron is trapped inside of it and is 
less active in producing biological damages. While, the pre-solvated electron is a precursor 
state of the solvated electron, it is surrounded by less water molecules than solvated electron 
and therefore, it is weakly bonded. The weakly bond pre-solvated electron, unlike its solvated 
state, is more efficient in producing DNA damages.  It has been a long controversy that at the 
molecular level, which water radiolysis species produces the most of biological damages. 
Conventionally, it is thought that ehyd− is less active in producing DNA damages and the 
majority of DNA damages are produced by OH• radical. However, the conventional picture 
was drawn in the absence of epre−. Due to its intrinsic high activity and high quantum yield, 
the fundamental role of epre− played in radiation chemistry and biology must be taken into 
consideration. In order to investigate the DNA damages induced by each radiolysis species, 
our group has conducted an experiment by adding different scavengers (KNO3, DMSO, and 
 12 
isopropanol) to liquid DNA samples during IR[25]. KNO3 is a scavenger for both epre− and 
ehyd− (OH• radical is one of the products from the KNO3 scavenging reaction). DMSO and 
isopropanol are effective scavengers for both epre− and OH• radical. These results have shown 
that epre− has a doubled efficiency in creating DNA strand breaks than the OH• radical. 
 
Based on the novel understanding on the lifetime and physical properties of epre−, a new 
molecular mechanism of reductive DNA damage was proposed by our group. As shown in 
Figure 1-4, we illustrated that in the process of water radiolysis, epre− and OH• radical are the 
two radicals with the highest quantum yields. The OH• radical can lead to oxidative DNA 
damages; while, the epre− having a lifetime of ~540 fs can attach to DNA to induce future 
DNA damages via dissociative electron transfer (DET) reactions (See Section 1.6). Our lab 
has confirmed that, in terms of the productivity of DNA single strand breaks (SSBs) and 
double strand breaks (DSBs), the reductive mechanism via epre− is at least twice as efficient as 
the oxidative mechanism via OH• radical. 
 
Figure 1-4. The schematic illustration of the reductive DNA damage mechanism. The epre− and OH• 
radical are the major water radiolysis products. It has been well-known that the OH• radical can lead 
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to oxidative DNA damages, while it was newly confirmed that epre−  can cause reductive DNA 
damages (SSBs and DSBs) via the dissociative electron transfer (DET) reactions.  This figure is 
adapted from [25] 
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1.5 Tumor hypoxia 
 
During the process of aggressive malignant growth, the development of vascular network 
inside the solid tumors is severely limited and the vasculature inside a solid tumor is 
dramatically different from that of a normal tissue[33]. In the normal tissue, the blood supply 
is maintained by an evenly distributed vascular network. The hierarchically organized 
vascular network can efficiently furnish fresh oxygen and other nutrients via blood vessels 
while wash away metabolic wastes from the interstitium via the lymphatic system. However, 
inside of the solid tumors, due to the fact that pro-angiogenic and anti-angiogenic molecular 
factors are abnormally secreted, the vascular system is lack of hierarchy. The blood vessels 
are either immature, tortuous, or occluded[34], while the lymphatic vessels are either leaky, 
dilated, or discontinuous[35]. The irregular vessel structure results in impaired oxygen and 
nutrition flow. Acute and chronic micro-regional hypoxia are generated consequently. 
Hypoxia can induce apoptosis and necrosis in both normal and cancerous cells[36]. In the 
year of 1955, by investigating the histological section of tumor tissues surrounded by 
vascular stroma, Thomlinson et al. reported[37] that there should exist a decreasing gradient 
of oxygen partial pressure (pO2) from the edge of the tumor cord toward its center; however, 
the cells between the necrotic center and the periphery of the tumor cord were still viable 
under hypoxic environment; therefore, they were more resistance to treatment.   
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Critical oxygen 
tension (mmHg) 
Biological effects observed below critical oxygen tensions 
0.2-15 Activation of hypoxia-inducible genes[38]–[41] 
15-30 Resistance to photodynamic therapy[42] 
25-30 Resistance to Low-LET radiation[43]–[45] 
30-35 Resistance to interleukin-2 triggered immunotherapies[46] 
Table 1-2. The inadequate oxygen supply inside solid tumors brings barriers to a variety of cancer 
treatments. Different hypoxia-induced biological effects were observed below different critical 
oxygen tensions. The oxygen partial pressure under which hypoxia-induced resistance to PDT, Low-
LET radiation and immunotherapy can be observed were 15-30, 25-30, 30-35 mmHg, respectively. 
This table is adapted from [47] 
 
 
Hypoxia can induce cell apoptosis and necrosis via different pathways. Hypoxia stimulates 
the expression of p53 gene, and p53 in a cell can be utilized as an indicator for the hypoxia 
induced p53-dependent apoptosis pathway, which involves Apaf-1 and caspase-9 as the 
downstream effectors[48]. The level of hypoxia-inducible factor-1 (HIF-1) can also be 
introduced as an indicator for the hypoxia-induced p53-independent apoptosis pathways[49]. 
Paradoxically, hypoxia-induced genome and protein changes can also promote the cancer 
cells to adapt to their hostile environment and, therefore, enhance the cancer cells’ 
proliferation and bring barriers to cancer treatments. A great portion of the hypoxia-inducible 
genes are regulated by transcription factors, such as HIF-1 and nuclear factor κB (NFκB). 
The threshold of oxygen partial pressure required to activate these hypoxia-induced 
transcription factors were reported to be under 15 mmHg for a variety of cancer cell lines 
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(see Table 1-2). Even though lack of quantitative data of hypoxia-induced chemo-resistance, 
a few in vitro and in vivo experiments have qualitatively shown that the potency of some 
chemotherapy agents, such as carboplatin and cyclophosphamide, were also oxygen 
dependent[50]–[52]. For immunotherapy, it was reported that the effectiveness of the 
interleukin-2 stimulated T-cell killing of cancer cells started to decrease when oxygen level 
was less than 35 mmHg (see Table 1-2).   
 
The hypoxic microenvironment inside of the solid tumors has also been a severe problem in 
cancer treatment, both photodynamic therapy and radiation therapy[45].  The potency of 
photodynamic agents and Low-LET radiation (x-ray radiation and γ-ray radiation) will be  
limited when the oxygen partial pressure is under 15-35 and 25-30 mmHg, respectively (See 
Table 1-2). The oxygen enhancement ratio (OER) is a measure of the enhancement of 
therapeutic effect under the exposure of IR in the presence of oxygen compared to the 
absence of oxygen. As shown in Eq. 1-10, the OER is defined as the ratio of the radiation 
dose required in hypoxia over the radiation dose required in normoxia to achieve the same 
level of biological effect.  
 
 
Eq. 1-10 
 
As the response of a cell to ionizing radiation strongly depends on its oxygen concentration, 
in the presence of oxygen, the radiation dose required to achieve the same tumor control 
probability is generally only one third of the dose required in the absence of oxygen (OER ≈ 
3)[43], [44], [53]. Therefore, oxygen is a potent radiosensitizer and its radiation enhancement 
mechanisms were thought to rise from two aspects: 1) the oxygen fixation hypothesis (OFH) 
ΟΕR=  radiation dose in hypoxia radiation dose in normoxia
 17 
(see Eq. 1-11)[54] and 2) the formation of oxygen free radicals, dominantly the superoxide 
radicals (O2•–) (see Eq. 1-12)[55]. 
 
 
 
 
Eq. 1-11 
 
  
Eq. 1-12 
 
The OFH was first developed in the 1950s and was widely accepted as the radiochemistry 
rationale for oxygen sensitizing effects[56]. Based on our unique understanding of the 
prosperities of per-solvated electrons, this hypothesis can be explained by the following 
processes (see Eq. 1-11): During IR, pre-solvated electrons and hydroxyl radicals are the 
major radical products with the highest quantum yields from water radiolysis; DNA is the 
principle target for these radicals and intensive indirect DNA damages will be produced by 
these radicals. In the absence of molecular oxygen, these DNA damages could be chemically 
repaired to their original state efficiently; while, in the presence of oxygen, the oxygen 
molecule will attach to a DNA damage site to form a non-restorable preoxy radical (•RO2), 
and make DNA damages hard to be repaired by the cell itself. In the latter case, the radical 
damages are thought to be ‘fixed’.   
 
If the mechanism of the oxygen effect in radiation therapy is solely a chemical process, as the 
OFH postulated, the production of the non-restorable preoxy radical should not depend on 
genetic identity of the irradiated cells. In the year of 1998, by exposing three different wild-
DNA + epre
− / •OH→ •R (DNA Damage)
•R+ O2→
•RO2(Damage fixed)
epre
− +O2 →O2
•− → DNA Damage
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type strains of E.coli to radiation, Ewing David showed that the maximum dose that did not 
alter the E.coli cells’ survival fraction was strain dependent. This experiment suggested that 
the OFH may not complete. Special attention must be given to the fact that even though, the 
fundamental chemistry proposed in the OFH is correct, OFH may not be able to cover the 
biological and enzymatic DNA repair pathways. 
 
 
Figure 1-5. The schematic illustration of the four-step single-electron reduction mechanism 
converting a molecular oxygen to a water molecule. The standard reductive potentials for each 
dioxygen derived product were listed respectively. These values were obtained from aqueous solution 
with oxygen at the standard atmosphere, PH value =7. This figure is adapted from [57].   
 
In the other aspect, the reduced production of superoxide radicals in the hypoxic environment 
could be another explanation of why a well-oxygenated cell requires less radiation dose to 
achieve the same level of cell killing effect comparing to a hypoxia cell.  
 
Radicals and molecules derived from molecular oxygen is the most important class of species 
that generated in a living system. They have substantial impact on many essential biological 
processes[58], [59] and are so-called reactive oxygen species (ROS). The four steps of the 
one-electron reduction mechanism that covers a molecular oxygen to a water molecule are 
illustrated in Figure 1-5. The formation of superoxide radical (O2•−), hydrogen peroxide, 
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hydroxyl radical and water molecule are stepwise shown with their standard reduction 
potential. As a consequence of the fact that superoxide radical is the first step product of the 
the entire reduction mechanism, the productivity of superoxide radical is the highest among 
all these species. It is reported that more than 2% of the total oxygen consumed in aerobic 
metabolism is utilized to produce superoxide radicals and the average annual production of 
superoxide radical in human is about 2 kg[60]–[62]. The superoxide radical has a slightly 
negative reductive potential (-0.16 V) and due to its unpaired electron, the superoxide radical 
has a considerable degree of activity. Conventionally, it was thought that superoxide radical 
can act both as a reducing agent[61] (Fe3+ can be reduced to Fe2+ by O2• −) and as an 
oxidizing agent[63] (O2• − can oxidize the thiol groups). Our group has recently revealed the 
function of O2• − in producing severe reductive DNA damages and suggested that O2• − might 
act as a strong reducing agent in many pathological and physiological processes[64]. 
 
Under normal circumstances, the majority of superoxide radicals are generated within 
mitochondria in a biological system. Mitochondria synthesize adenosine triphosphate (ATP), 
the fuel that drives all of the physiological activities, through a mechanism that is so-called 
the electron transport chain (ETC)[65]. Even under an ideal condition, some electrons can 
still leak from ETC and interact with oxygen to form superoxide radicals. Except for 
mitochondria, other cell organelles such as endoplasmic reticuli, lysosomes and cytoplasmic 
membranes can also generate superoxide radicals during their routine hydroxylation and 
oxidation reactions[57].  It is noteworthy that superoxide radicals are more likely to be 
generated in the cell organelles rather than in the nucleus; therefore, the organelle genes have 
higher tendencies to be damaged by superoxide radicals under usual circumstances.  
 20 
 
Under unusual circumstances where exogenous stresses such as ionizing radiation or 
ultraviolet photons are presented, the formation of superoxide radicals can be mediated non-
enzymatically[66]. Pre-solvated electrons can be generated inside the nucleus from the 
radiolysis of water. When oxygen molecule is close to the pre-solvated electron, the electron 
will attach to the oxygen molecule to form a superoxide radical. The superoxide radicals can 
be eliminated by a cell either spontaneously or by superoxide dismutase (SOD) and the 
energy of the superoxide radicals are also transferred to nucleus DNA (see Eq. 1-12) and 
other subcellular targets along these processes. In the aqueous environment inside a cell, the 
superoxide radical has a very short lifetime[67], [68] and cannot diffuse far enough to 
produce significant direct damages. However, it has an electron affinity about -0.5 eV. The 
negative electron affinity suggested that superoxide radical has the tendency to donate one 
electron rather than capture one. Therefore, it is relatively easy for a superoxide radical to 
eject an electron and be oxidized. When the ejected electron is attached to DNA, the 
dissociative electron transfer reaction will inflict DNA to cause bound rupture, nucleotide 
breakage, and other irreversible reductive DNA damages[64]. 
 
For hypoxia cancer cells, the limited intrinsic oxygen level accounts for the fact that excess 
of pre-solvated electrons exist after exposing to IR (the pre-solvated electrons are less likely 
to be eliminated through Eq. 1-12). There is no doubt that pre-solvated electrons can create 
severe DNA damages; however, considering pre-solvated electrons’ ultrashort lifetimes, high 
reactivity, and the complex environment inside a tumor cell, a compound that can mimic the 
mechanism of oxygen by letting a pre-solvated electron weakly bond to it and producing 
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further DNA damages via DET reaction would be a good candidate to increase the IR 
induced indirect DNA damages in hypoxic cells. 
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1.6 DET based radiosensitizer 
 
The definition of “dissociative electron transfer (DET)” is an ultrafast electron transfer 
(~femtosecond) of a weakly bound electron to a transition molecule, AB, and then the 
chemical bond of AB is broken, AB dissociates into fragments:  
  
Eq. 1-13 
 
As the definition suggested, the term “DET” refers to a process occurs when a weakly-bound 
electron (< 0 eV) from either an atom, a molecule, or the polar medium rapidly transfers to a 
transition molecule, forming a transient negative ion (TNI). Then, the fragments (A and B) 
will be produced from the dissociation of the TNI. As shown in Eq. 1-13, when considering 
DNA is the target, the dissociated AB fragments could be radicals and the resultant radicals 
could inflict DNA damages. The source of the electron could either the radiolysis of bio-
molecules (most likely the water molecules) under ionizing radiation or the reductive 
intracellular environment of a cancer cell.  
 
Based on our fresh understanding about the properties of pre-solvated electrons, a family of 
compounds with radiosensitivity through the DET reaction have been discovered by our 
group by utilizing the fs-TRLS techniques[16]. These compounds are so-called 
femotomedicine (FMD) compounds. In-vivo and in vitro experiments have already shown 
that these FMD compounds are potent anticancer agents for chemotherapy and could be 
effective radiosensitizer for radiation therapy[16], [69]. The advantages of these FMD 
compounds over the conventional platinum-based anticancer agents are 1) the FMD 
e− (< 0 eV, < 1ps)+ AB→ AB*− → A (+ B− ) → DNA damage
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compounds do not contain platinum (the heavy metal which is cytotoxic and hard to be 
eliminated by human body); therefore have better pharmacokinetic properties; 2) the FMD 
compounds have the natural selectivity that shown far less cytotoxicity and radiotoxicity on 
human normal cell lines than on the human tumor cell lines[16], [69]; 3) the FMD compound 
molecules are sufficiently effective in DET reactions and the DET reactions could be even 
more effective in hypoxia tumor environment. 
 
The DET reaction of the FMD compound can be described as the following: Pre-solvated 
electrons are either created from IR of water or from the reductive environment of a cancer 
cell. If pre-solvated electrons are not captured by a transition molecule (either a FMD 
compound or DNA), they will quickly get solvated by the surrounding water molecules to 
form solvated electrons. When a FMD compound is present, the pre-solvated electron will 
dissociatively attached to a FMD compound and the negative transient ion, FMD–, will be 
formed. The potential energy curve for FMD– is much lower than the potential energy curve 
for the FMD; therefore, the ultrafast effective resonant DET will occur and FMD compound 
will dissociative into fragments. These resultant radical fragments can effectively cause DNA 
damages and subsequently kill the cancer cells.   
 
In the presence of molecular oxygen, there should be a competition binding of pre-solvated 
electrons between FMD compound molecules and oxygen molecules. Due to the fact that 
FMD– compound molecules are more efficient in producing DNA damages than the O2• –, the 
FMD compound should be more effective in the hypoxic environment than in the normoxic 
environment. The major task in this project is to carry out in vitro tests to verify if the FMD 
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compound’s radiosensitizing effect is enhanced in hypoxia cancer cells and to perform 
quantitatively analysis, to calculate the enhancement ratio. 
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Chapter 2 Steady-state absorption spectra 
analysis of the radiolysis of the FMD 
compound 
 
 
2.1 Introduction 
 
Spectroscopy is one of the most fundamental techniques in analytical chemistry study and 
biochemical study. It is a quantitative measurement of the interaction between 
electromagnetic (EM) radiations and the irradiated samples. In the 17th century, by refracting 
white sunlight beams with a prism, Isaac Newton provided the first scientific analysis of 
spectroscopy in the world. There are many types of spectroscopy that have been developed, 
such as atomic absorption spectroscopy, Raman spectroscopy, microwave spectroscopy, 
fluorescence spectroscopy, ultraviolent/visible (UV/Vis) spectroscopy, infrared (IR) 
spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, etc. Among all these 
techniques, the UV/Vis spectroscopy provides researchers the simplest and cheapest way to 
get an access to a variety of properties of a sample, such as the concentration of a sample, the 
solubility of a solute, the rate constant of a reaction, etc. Therefore, the static UV/Vis spectra 
measurement was chosen as the first experiment in this thesis. 
 
The simplified working mechanism of a single beam UV/Vis spectroscopy is illustrated in 
Figure 2-1. A UV/Vis spectroscopy consists of three parts, they are 1) a lamp, 2) a 
monochromator, 3) a cuvette holder and 4) a photodetector. The lamp provides a continuous 
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stable light source from ultraviolet region to visible region for the system. The 
monochromator separates the light beam into different fractions spatially by the wavelength. 
The light beam with the selected wavelength can pass through the cuvette holder and the 
intensity of the transmission light is recorded by a photodetector. The data is collected by the 
data acquisition card and the spectrum is then plotted for future analysis. For solutions at low 
concentration, the absorbance of the incident light by the sample can be described by the 
Lambert-Beer’s Law. 
 
 
Figure 2-1 A simplified schematic illustration of the working function of a UV/Vis spectroscopy. 
Light beam with a specific wavelength is generated from a monochromator. After passing through a 
cuvette which contains the sample, the light intensity is decreased and the signal is recorded by a 
photodetector. The absorbance of incident light is described by the Lambert-Beer’s Law.  
 
As shown in Figure 2-2, the Lambert-Beer’s law is a famous quantitative relationship 
between the concentration of a coloured substance in a homogeneous solution and the 
amount of light the solution absorbed. 
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Eq. 2-1 
 
Where Abs is the absorbance of the sample, I0 is the intensity of the incident light, I 
represents the intensity of the transmission light, ε is the molar extinction coefficient, l is the 
length that the incident light travels, and c is the molar concentration of the solute.   
 
The geometric properties of a given cuvette are fixed, which means the distance that the 
incident light travels, l, is a constant. At low concentrations, the molar extinction coefficient 
is a constant, the molar extinction coefficient, ε, is a constant; therefore, a linear relationship 
between absorbance of the sample and the concentration of the substance is expected.  
 
 
Figure 2-2. The schematic illustration of the Lambert-Beer’s Law. The incident light is absorbed by 
the solute, and the intensity of the transmission light is therefore attenuated along the path. Based on 
the Lambert-Beer’s Law, the absorbance is proportional to the concentration of the solute.  
Abs =log I0 I
⎛
⎝⎜
⎞
⎠⎟
= εlc
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2.2 Method 
 
2.2.1 Chemicals and reagents 
To prepare the FMD compound stock solution, 5.3 mg of the FMD compound was weighted 
by an analytical balance and then dissolved in 1000 µL of ethanol to make a 20 mM FMD 
compound stock solution. For this steady-state absorption spectroscopy experiment, the 100 
µM FMD solution sample was prepared by mixing 150 µL of the 20 mM FMD compound 
stock solution with 30 mL of ultrapure water (TOC< 1ppb, Resistivity = 18.2 MΩ-cm). The 
ultrapure water was directly obtained from the Barnstead Nanopure water system.  
 
2.2.2 Steady-state absorption spectroscopy 
All the steady-state absorption spectra in this chapter were obtained using a Beckman Coulter 
DU 530 UV/Vis spectroscopy. First, 400 µL of the FMD solution sample (100 µM) was 
added into a cuvette, the steady-state absorption spectrum was then measured. The peak of 
the absorption spectrum was in the range of 1.5-1.7, which proved that the Lambert-Beer’s 
Law can be applied to this sample. Then, different quartz cuvettes were filled with 400 µL of 
the sample and are either bubbled with air, nitrogen, or argon gas for half an hour, protected 
from light. After bubbling, totally 40Gy of radiation dose was evenly divided into 4 fractions 
(10Gy each) and applied to the cuvettes. The steady-state absorption spectra of these cuvettes 
were then measured before and after irradiation.  
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2.2.3 Hypoxic environment system 
To create a hypoxic environment, the cuvettes that contained the FMD solution samples were 
bubbled with compressed nitrogen and argon gas. The high purity nitrogen and argon gas 
were ordered from Praxair, and the purity was > 99.998%. For the control group, the samples 
were bubbled with air. The bubbling system, as shown in Figure 2-3, was consisted with a 
long needle, a short needle, and a rubber plug with parafilm wrapped around it. The gas was 
bubbled into the cuvette through the long needle and was exhausted through the short needle. 
The cuvette was sealed with a rubber plug and parafilm. The sample was prevented from 
light, and was bubbled for half an hour with a constant rate (1-2 bubbles per second). 
 
 
Figure 2-3. The experimental apparatus diagram of the bubbling system. The gas flows into the 
cuvette through the long needle, which was immersed into the very bottom of the cuvette. The short 
needle, which was above the fluid level, acted as the exhaust vent. The system was sealed by the 
rubber plug and parafilm. 
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2.3 Results 
 
To determine if the FMD compound is sensitive to IR, 400 µL FMD solution sample (100 
µM) was added into a cuvette, bubbled with air for half an hour, and then irradiated with 
10Gy X-ray radiation 4 times. The steady-state UV/Vis absorption spectra of the sample 
were measured before and after irradiation. The difference spectra between each irradiated 
sample and the control group (without exposing to IR) were also plotted (see Figure 2-4). 
The difference spectra were amplified by 10 times. Each of the difference spectra has a peak 
at 220 nm. The decrease of the absorbance after irradiation shows that FMD compound is 
indeed sensitive to X-ray radiation.  
 
Figure 2-4. The steady-state UV/Vis absorption spectra of the FMD solution sample (100 µM) after 
being exposed to different doses of IR. These spectra were measured at room temperature. Prior to 
radiation, the sample was bubbled with air for half an hour, protected from light. The difference 
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spectra between each irradiated samples and the control group were also plotted. The decrease of 
absorbance suggested that FMD compound is sensitive to IR. 
 
To determine if the FMD compound is more sensitive to IR in the hypoxic environment, 400 
µL FMD solution sample was added into a cuvette, then the FMD solution sample was 
bubbled with nitrogen, instead of air, for half an hour, protected from light. 40 Gy of X-ray 
was applied to the sample in 4 fractions. The UV/Vis absorption spectra were measured 
before and after being exposed to IR. The results were shown in Figure 2-5. In order to 
exclude the effect of the reactive nitrogen species, this experiment was repeated by bubbling 
the sample with argon gas. The results were also shown in Figure 2-5. The difference spectra 
were plotted. It seems that the difference spectra of samples bubbled with nitrogen were 
identical with the difference spectra of samples bubbled with argon. By comparing the 
difference spectra of the N2/Ar bubbled sample with the difference spectra of the air bubbled 
sample, one can see that in hypoxic environment, the FMD compound is more efficiently 
dissociated by IR. As all the difference spectra have a peak at 220 nm, the absorbance 
decrease of the samples at 220 nm has provided us a quantitative measurement of 
radiosensitivities of the FMD compound in either air, N2, or argon conditions. The decrease 
rate of FMD compound was calculated as the change of absorption over the change of 
radiation dose, and it can be obtained from the linear fit of the radiation induced absorbance 
decrease at 220nm. As shown in Figure 2-6 , in nitrogen and argon condition, the decrease 
rates were almost the same (0.01700.0008), in air condition, the decrease rate was 0.0015
0.0005. The hypoxic environment enhanced the radiosensitivity of FMD compound by 
about 9 times.  
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Figure 2-5. The steady-state UV/Vis absorption spectra of the FMD solution sample (100 µM) exposed to different dose of IR. The spectra were 
measured at room temperature. Prior to radiation, the sample was bubbled with N2/Argon for half an hour, protected from light. The difference 
spectra between each irradiated sample and the control group were also plotted. The difference spectra were magnified by 10 times.   
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Figure 2-6. The absorbance decrease at 220 nm of the irradiated FMD solution sample (100 µM). The 
samples were irradiated by different doses of X-ray under either air, nitrogen, or argon gas 
environment.  The decrease rate showed a linear dependent to the radiation dose. The decrease rates 
were obtained from the linear fit of the radiation induced absorbance decrease. In nitrogen and argon 
environment, the decrease rates were almost the same (0.01700.0008), which was 9 times faster 
than the decrease rate in air environment (0.00150.0005). 
 
 
 
  
 34 
2.4 Conclusion 
 
In this experiment, we confirmed that the FMD compound is sensitive to IR. This is one of 
the most fundamental characteristics for a potential radiosensitizer. By comparing the 
decrease rates of the steady-state absorption spectra of the irradiated FDM compound 
solutions, we also confirmed that under hypoxic environment, the radiosensitivity of the 
FMD compound was increased by 9 folds. The mechanism is proposed to be as the following:  
• In the presence of oxygen, after the radiolysis of water, epre− will either be captured by 
oxygen molecules to form the O2• − radicals, or dissociatively attached to FMD 
molecules.  If it is attached to the a FMD molecule, the FMD molecule will dissociate 
into fragments; therefore, the absorbance of FMD compound will be reduced. The 
dissociative FMD radical fragments might have anticancer activities (will be 
discussed in next chapter); therefore, after dissociation, the FMD compound is 
considered to be activated (see Eq. 2-1). 
 
• In the absence of oxygen, there will be no competition binding of epre− between 
molecular oxygens and the FMD compounds. Therefore, more FMD compounds will 
dissociate into radical fragments due to the excess of epre− (see Eq. 2-2 ).  
  
Eq. 2-3 epre
− + FMD→ FMD•− →More Activated FMD
  
Eq. 2-2 epre
− +O2 + FMD→O2
•− + FMD•− → Activated FMD
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Chapter 3 In vitro DNA double strand 
breaks measurement 
 
3.1 Introduction 
 
Exogenous stress, such as cytotoxic chemical agents, ionizing radiation beams, or 
ultraviolent light, can lead to a variety of DNA damages in a tumor cell. Some of the DNA 
damages, such as base alterations and single strand breaks, can be instantly repaired by a cell. 
Among all these DNA damages, double strand break (DSB) is the most lethal type. During 
the normal life of a cell, the genome damages of the cell are continuously arising, but the 
DSBs are rare events. Cells, especially cancer cells, may lack of enzymes to correctly repair 
double strand breaks comparing to that for other types of DNA damages[71]. Therefore, 
double strand breaks are very difficult to be repaired, and if not repaired correctly, fusions, 
deletions, and translocations could happen in the adjacent DNA sequences, programmed cell 
death (apoptosis) will be initiated[72].  
 
Currently, there are many methods that are used for the detection of DNA DSBs, such as gel 
electrophoresis, pulsed-field gel electrophoresis (PFGE)[73], and !-H2AX labeling. The gel 
electrophoresis can be used to detect DNA fragments less than 50kb, the PFGE can be used 
to isolate DNA fragments with higher molecular weights. By utilizing !-H2AX labeling, 
DNA DSBs can be visualized with cell-by-cell resolution, and can be quantified through 
fluorescence microscopy, without rupturing the cell membranes and extracting the DNA. 
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Therefore, !-H2AX labeling has become an increasingly popular succedaneum to the other 
DNA DSBs detection methods.  
 
In mammalian cells, DNA is wound on histone-groups to form a condensed structure unit, 
which is called a nucleosome. In the center of each nucleosome core particle, there is an 
octamer of core histones, which is warped by about 146 base pairs of DNA[74]. The histone 
octamer is consisting with one H3/H4 tetramer and two H2A/H2B dimmers. Therefore, H2A, 
as one of the core histones, has substantial impact on the formation of nucleosomes as well as 
the function of DNA. H2AX is a subtype histone belongs to the H2A histone family. H2AX 
can be phosphorylated in the position of Ser139 by kinases such as ATM (ataxia 
telangiectasia mutated), ATR (ATM-Rad3-Related), or DNA-PK (DNA dependent protein 
kinase)[75]. Within a few minutes after exposing to genotoxic agents or ionizing radiation, 
DNA DSBs will take place. In the adjacent to the breaks, H2AX will be phosphorylated[76]. 
The phosphorylated H2AX, !-H2AX, is essential for the assembly of DNA repair proteins 
and for the activation of checkpoints proteins[77]. The !-H2AX foci have a 1:1 relationship 
with DSBs[78]; therefore, !-H2AX can be used as a biomarker to represent DNA DSBs. To 
visualize the DSB by immunofluorescence, we first add	 !-H2AX antibodies to selectively 
detect the !-H2AX foci, then secondary antibodies are added for the amplification of the 
fluorescence signal. 
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3.2 Method 
 
3.2.1 Cell culture 
The human lung cancer cells, A549 (ATCC® CCL-185™) were purchased from the 
American type culture collection (ATCC). Cells were grown in Kaighn’s Modification of 
Ham’s F-12 (F-12K) medium supplemented with 10% fetal bovine serum (Invitrogen) and 1% 
penicillin-streptomycin (PS) solution (ATCC® 30-2300™). The cells were incubated in 10% 
humidified atmosphere with continuous 5% of CO2 supply at 37 , and were passaged twice 
a week. 
 
3.2.2 Radiation treatment 
The logarithmic phase A549 cells were seeded in black 96-well plates at a density of 2500 
cells/well. Following a 24 hours’ incubation, in order to let the cells attached to the bottom of 
the plates, the cell culture medium in the plates was replaced by fresh medium containing 
either 0 or 40 µM of FMD compound. Cells were incubated for 6 hours. After that, the plates 
for the hypoxia treated cells were placed in our hypoxic environment system for 2 hours; 
while, the plates for the normoxic cells remain in the incubator. Then, the plates were 
irradiated with either 0 or 10 Gy of X-Ray dose by a 225 KV X-ray machine (Precision, X-
RAD IR225) at a dose rate of 2.5 Gy/mins. After IR, the hypoxia treated cells were taken 
from our hypoxic environment system and incubated together with the normoxic cells for 
two days. After the two days’ incubation, the !-H2AX detection assay was performed to the 
cells. The yield of DSBs were analysed by the software Image J (See Figure 3-1). 
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Figure 3-1. The schematic diagram of the radiation treatment of A549 cells. Following a 24 hours’ 
incubation, the cells were treated with 0 /40 µM of FMD compound for 8 hours. For hypoxia treated 
cells, in the last two hours of the 8 hours’ drug treatment, plates were sealed in our hypoxic 
environment system. Then 10 Gy of X-ray was applied to the cells. After radiation, the cells were 
incubated for 2 days in a regular cell incubator. Eventually, !-H2AX detection assay was performed 
to the cells.  
 
3.2.3 Hypoxic environment system 
The hypoxic environment system (see Figure 3-2) was designed with the help of my 
colleague, Wei Hong, and the idea was inspired by Wang et al. [79].  In brief, the hypoxia 
condition was achieved by flowing compressed gas mixture (95% N2, 5% CO2, directly 
ordered from Praxair) into a large Ziploc® double zipper produce bag (purchased from 
Walmart). The working process is described as the following: a multi-well plate was placed 
into the zipper bag in advance, then the bag was flushed by the gas mixture for 3 times before 
the bag was filled with the gas and sealed. The sealed bag was then placed in an incubator for 
2 hours at 37 . Once sealed, it took 0.5-2 hours for the oxygen concentration eventually 
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reached equilibrium between the cell culture medium (inside the multi-well plate) and the 
surrounding gas mixture[79], [80]. Therefore, during the 2 hours’ hypoxia treatment, the gas 
inside the zipper bag was refilled 6 times in order to extirpate any oxygen, which may emit 
from the cell culture medium. 
 
 
 
Figure 3-2. The experimental apparatus diagram of the hypoxic environment system. The cancer cells 
were seeded in the multi-well plates, and the plates were sealed in double zipper bags which contains 
95% N2 and 5% CO2. The sealed bags were incubated at 37  for a desired period of time,  then X-
ray was applied to the cells which were sealed in the double zipper bag. 	
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3.2.4 !-H2AX detection kit 
HCS DNA damage kit (Invitrogen, Catalog # H10292) was used in this experiment for the 
detection of the DNA DSBs. In this kit, Alexa Fluor® 555 goat anti-mouse IgG was used to 
selectively bind to the DNA DSBs sites and produce red emissions. The Hoechst 33342 was 
used to stains nuclear DNA and produce blue emissions. This kit was used following the 
standard protocol provided by the manufacturer. In brief, Image-iT DEAD Green™ viability 
stain was added to the cells and the cells were incubated for half an hour in a regular cell 
incubator. Then, the cells were fixed, permeabilized, and blocked. Following that, the !-
H2AX primary antibody, Alexa Fluor® 555 secondary antibody, and Hoechst 33342 nuclear 
counterstain were added to cell sequentially. Finally, the cells were washed thoroughly to 
remove all the excess antibodies. The immunofluorescence microscopy pictures of the cells 
were taken by a Nikon Eclipse TS1000 microscope, and the intensity of !-H2AX per cell 
was quantitatively analysed by Image J software. 
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3.3 Results 
 
To determine if the FMD compound can induce more DNA DSBs in hypoxic environment, 
A549 cells were treated with/without 40 µM of FMD compound and exposed to 0/10Gy of 
X-Ray radiation in normoxia/hypoxia conditions.  The yield of DNA DSBs were represented 
by the intensity of !-H2AX per cell. The images were shown in Figure 3-4. The blue 
fluorescence represents the stained nuclear DNA and the red fluorescence is from the !-
H2AX foci. A quantitative analysis of the yield of !-H2AX was shown in Figure 3-3.  
 
First, by comparing the yield of DNA DSBs (intensity of the !-H2AX foci) between the 
control groups (the groups without FMD compound treatments), one can see that the 2 hours’ 
hypoxia treatment increased the yield of DSBs for the non-irradiated cells, but decreased the 
yield of DSBs for the irradiated cells. The increase could be explained as the hypoxic 
environment introduced exogenous stress to the cancer cells, and it therefore increased the 
instability of the DNA; while the decrease can be explained by the oxygen enhancement 
effect as discussed thoroughly in the previous chapter. In the absence of oxygen, the DNA 
DSBs will not be fixed by oxygen and there is also no O2• – to damage to DNA through the 
DET reaction, the yield of DSBs in the hypoxic environment are therefore less than the yield 
of DSBs in the normoxic environment. The decrease also proved that our hypoxic 
environment system successfully maintained the low level of oxygen during the experiment 
period.   
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Then, by comparing the groups that were treated with 40 µM of the FMD compound, one can 
see that even though the FMD compound showed some genotoxicity for the non-irradiated 
cells, an increase of DNA DSBs was observed both in normoxic environment and in hypoxic 
environment after radiation. Moreover, the increase in the hypoxic environment is more 
significant than that in the normoxic environment.  
 
 
 
Figure 3-3. !-H2AX DNA DSBs detection in A549 cancer cells treated by the FMD compound 
combined with X-ray radiation. A549 human lung cancer cells were treated with/without 40 µM of 
FMD compound for 8 hours, followed by 0/10Gy X-Ray radiation in normoxia/hypoxic environment. 
2 days after irradiation, !-H2AX DNA DSBs detection assay was performed. The intensity of !-
H2AX is proportional to the yield of DSBs per cell. 
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Figure 3-4. Image of X-radiation-induced genotoxicity of FMD compound in A549 human lung cancer cells using the HCS DNA Damage Kit. 
A549 cells were treated with 40 µM FMD compound for 8 hours. During this period, the normoxia cells were incubated at 37 , 95% Air, 5% 
CO2, while the hypoxia cells were incubated at 37 , 95% Air, 5% CO2 for 6 hours and 37 , 95% N2, 5% CO2 for 2 hours.  
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3.4 Conclusion 
 
In this experiment, it was confirmed that the FMD compound is a sensitive DNA damaging  
agent under IR. The proposed mechanism is described as the following:  
• In the normoxic environment, the epre−, which was generated from the radiolysis of water, 
was either absorbed by an oxygen molecule to form the a O2• −, or dissociatively attached 
to the a FMD molecule to form FMD radical fragments. However, the O2• − is less 
effective in creating DNA DSBs compared to the FMD radical fragments. The high level 
of oxygen in the normoxic environment will lead to the loss of effectiveness of FMD 
compound. 
  
Eq. 3-1 
 
• In the hypoxic environment, there were more epre− that can dissociatively attached to 
FMD molecules, the activation of the FMD compound consequently lead to the increase 
of the yield of DNA DSBs. 
  
Eq. 3-2 
 
We therefore conclude that, FMD compound has moderate genotoxicity in the absence of 
radiation; however, when combined with IR, FMD compound is highly effective in 
producing DNA damages, especially DNA DSBs, in hypoxic cancer cells. 
epre
− +O2 + FMD→O2
•− + FMD•− → Activated FMD→ DNA Damages
epre
− + FMD→ FMD•− →More Activated FMD→More DNA Damages
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Chapter 4 Activated caspase assay of 
apoptosis measurement 
 
4.1 Introduction 
 
DNA damages could lead to programmed cell death, namely, apoptosis, pyroptosis, and 
necroptosis. Caspases are key components in the molecular identification of this intracellular 
suicide program[81]–[83]. During the process of programmed cell death, the activation of 
caspase enzymes will keep any impact on the surrounding tissues to a minimum[84]. Caspase 
deficiency has been reported as a inducement for tumor initiation[85], on the contrary, the 
over activation of caspase may result in neurodegenerative diseases, such as Alzheimer’s 
disease (AD)[86].   
 
One of the most distinctive features of early stage of apoptosis is the activation of caspases. 
There are two major pathways for the activation of caspase. 1) the cell surface death receptor 
pathway[87] and 2) the mitochondria initiated pathway. In the death receptor pathway, the 
activation of caspase 8 aids in the cleavage of the downstream protein, Bid (BH3 interacting-
domain death agonist) protein, and the activation of the downstream caspase, caspase 3. In 
the mitochondria initiated pathway, the activated caspase 9 can activate downstream caspases, 
caspase 3, 6, and 7. It was also reported that there exists cross-talk between these two 
pathways[88]. Caspase 3 is considered as the convergence point of these two signalling 
pathways, as caspase 3 can be activated either by caspase 8 or 9. Therefore, the detection of 
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the activated caspase 3 provided us a reliable and convenient approach to monitor the 
apoptosis process. 
 
To detect the activation of caspase 3, molecular probes consisting of a short peptide, DEVD, 
and a DNA binding dye were added into the tested cell. As shown Figure 4-1,when apoptosis 
starts, the activated caspase 3 will cleave the linkage between DEVD and the DNA binding 
dye[89]. Therefore, the DNA binding dye will be released by caspase 3. The released dye 
will bind to DNA, and emit green florescence after excitation. Eventually, apoptosis can be 
quantified via immunofluorescence microscope. 
 
 
Figure 4-1. The schematic illustration of the working mechanism of the Caspase 3 detection probes. 
The activation of caspase 3 represents the apoptosis process of the cell death. The detection probe is 
consisted with a short peptide, DEVD, linked to a DNA binding dye. Activated caspase 3 can cleave 
the linkage and release the dye. The released dye can then bind to DNA and emit a bright green 
florescence after excitation. 
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4.2 Method 
 
4.2.1 Cell culture 
The human cervical cancer cells, HeLa (ATCC® CCL-2™) were directly purchased from the 
American type culture collection (ATCC). Cells were grown in Eagles Minimum Essential 
Medium (MEM) containing 10% fetal bovine serum (Invitrogen) and 1% penicillin-
streptomycin (PS) solution (ATCC® 30-2300™). The cells were incubated at 37  in a 
regular CO2 incubator, CO2 level was maintained at 5%, and relative humidity was 
maintained at 10%. The cells were passaged twice a week. 
 
4.2.2 Radiation treatment 
The radiation treatment is almost the same as it has been described in the previous chapter. 
The HeLa cells in the logarithmic growth phase were seeded in black 96-well plates at a 
density of 2000 cells/well. 0/4/8 µM of FMD compound were added with fresh medium after 
24 hours of seeding. Then, the normoxic cells were incubated in a regular incubator for 8 
hours; while the hypoxic cells were incubated in a regular incubator for 6 hours and then 
sealed in the hypoxic environment system for 2 hours (as described in last chapter). 
Following that, 0/5/10 Gy of X-ray (Precision, X-RAD IR225) were applied to these cells at 
a dose rate of 2.5 Gy/mins. After radiation, both of the normoxic cells and the hypoxic cells 
were incubated in a regular cell incubator for 2 days for the final detection of activated 
caspase. 
 
 48 
 
4.2.3 Caspase detection kit 
CellEvent™ Caspase-3/7 Green Detection Reagent (Invitrogen, Catalog # C10423) was used 
for the detection of activated caspase. The kit was used following the protocol provided by 
the manufacturing company without further modification. In brief, the cells were treated with 
different doses of FMD compound and X-ray radiation in normoxia/hypoxia conditions, 2 
days after radiation, the cells were incubated with CellEvent™ Caspase-3/7 Green Detection 
Reagent (2 µM) for half an hour in normal incubation condition. The pictures of the cells 
were taken via a Nikon Eclipse TS1000 microscope. The apoptotic cells can be excited at 
502 nm, and the emission is 530 nm. The number of apoptotic cells were then counted by 
eyes. The percentage of cells with activated caspase is defined as the ratio of the number of 
apoptotic cells to the total number of cells. 
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4.3 Result 
 
The images for the apoptosis analysis in the treated human cervical cancer cells (HeLa) were 
shown in Figure 4-3. The cells with green emission were apoptotic cells, and the green 
emission was from the activation of caspase 3. In the absence of radiation, as the 
concentration of the FMD compound increased, there was an increase in the percentage of 
apoptotic cells. This result suggests that the FMD compound has intrinsic cytotoxicity. In the 
presence of the FMD compound, the percentage of apoptotic cells was increased with 
radiation dose, this result shows that the FMD compound indeed has radiosensitivity.   
 
The quantitative analyses of these figures were provided in Figure 4-2. It can be seen that in 
the absence of the FMD compound, after being exposed to 10Gy X-ray radiation, 19.52.0 % 
of apoptotic cells were observed in normoxia condition, but only 12.11.2 % were observed 
in hypoxia condition. The reduction of the IR induced apoptosis in hypoxia condition showed 
consistency with our previous DNA DSBs observation. Not surprisingly, cancer cells showed 
resistance to radiation in the hypoxic environment. However, by comparing the percentages 
of apoptosis between the radiated cells treated with/without FMD compound, one can see 
that with 8 µM of the FMD compound, the percentage of apoptosis was increased both in 
normoxia and hypoxia conditions. The increase in hypoxia condition (5-folds increment) was 
significantly higher than that in normoxia condition (2-fold increment). 
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Figure 4-2. The quantitative measurements of apoptosis in human cervical cancer cells (HeLa) treated 
by 0/8 µM of the FMD compound with 0/10Gy of X-ray radiation under normoxia/hypoxia 
conditions. The percentage of cells with activated caspases, the ratio of the number of cells with green 
fluorescence to the total number of cells in an image, represents the percentage of apoptotic cells in 
the whole population.   
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Figure 4-3. Images of the human cervical cancer cells with activated caspase. Hela cells were treated with 0/4/8 µM of the FMD compound 
followed by 0/5/10 Gy of X-ray radiation. At 2 days’ post-irradiation, the caspase detection reagent was added. The apoptosis in Hela cells were 
represented by green fluorescence. The cells on the left panels were irradiated under normoxia condition, the cells on the right panels were 
irradiated under hypoxia condition. 
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4.4 Conclusion 
 
In this experiment, it was proved that the FMD compound has radiosensitivity that can 
increase apoptosis in human cancer cells. It was also proved that the radiosensitivity was 
increased by the hypoxic gas environment but limited by the normoxic gas environment. The 
proposed mechanism is described as the following: 
• In the normoxia condition, the excess of oxygen will limit the attachment of the pre-
solvated electrons and the FMD molecules. Only a limited number of FMD molecules 
could be activated in the presence of oxygen. 
  
Eq. 4-1 
 
• In the hypoxia condition, the FMD molecules have more chance to be dissociatively 
attached by a pre-solvated electron. The dissociated FMD fragments were efficient in 
increasing apoptosis. Therefore, the FMD compound’s radiosensitizing effect is more 
significant in the absence of oxygen.  
 
  
Eq. 4-2 
 
 
 
 
epre
− +O2 + FMD→O2
•− + FMD•− → Activated FMD→ Apoptosis
epre
− +O2 + FMD→O2
•− + FMD•− → Activated FMD→More Apoptosis
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Chapter 5 Clonogenic assay 
 
5.1 Introduction 
 
Clonogenic assay and MTT assay are the two most popular in vitro techniques to evaluate the 
potency of anticancer agents.  Clonogenic assay is widely used to determine the proliferation 
and survival of the irradiated cancer cells, while the MTT assay is commonly used to 
evaluate the cancer cell variability (metabolic activity) after treated with cytotoxicity 
molecules[90].  
 
In radiobiology, for the proliferating cells, if a cell lost its ability to proliferate infinitely and 
cannot produce a large number of offsprings, this cell is considered as dead. The clonogenic 
assay is to test the capability of a single cell to proliferate into a large colony. Generally, the 
clonogenic assay is composed of five steps: cell preparation, cell treatment, plating, staining, 
and counting (more details will be given in the method section). A colony can be recognized 
by naked eyes are of at least 50 cells[91]. The MTT assay is a colorimetric assay, the cells 
with metabolic activities can reduce MTT to formazan crystal, a purple-colored product. The 
quantity of formazan formed can represent the cell’s variability. The MTT assay is a fast and 
inexpensive test, but it is not able to directly get access to the cytocidal activity and the 
number of cells[92]. More importantly, the metabolic states between normoxic cells and 
hypoxic cells are different. The difference in metabolic states result in the fact that the MTT 
results cannot be crosswisely compared between normoxic and hypoxic groups.  
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Therefore, in order to determine if the FMD compound can efficiently decrease the cancer 
cells’ survival when combined with radiation, and to compare the sensitizing effect between 
hypoxia and normoxia, clonogenic assay, rather than MTT assay, should be conducted in this 
experiment.  
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5.2 Method 
 
5.2.1 Cell culture 
A549 human lung cancer cells were used in this experiment. Cell line information and cell 
culture conditions are identical with Chapter 3. 
 
5.2.2 Radiation treatment 
The flow chart of the cell treatment can be seen in Figure 5-1. The logarithmic phase  A549 
cells were seeded in 6-well plates at various densities as shown in Table 5-1. First, the cells 
were incubated regularly at 37  , 5% CO2, 95% Air, for 24 hours. Then different 
concentrations of the FMD compound were added to these 6-well plates, the normoxic cells 
were then incubated in incubator for 8 hours, while the hypoxic cells were incubated in 
incubator for 6 hours, and then sealed in the hypoxic environment system (37 , 5% CO2, 
95% N2) for 2 hours. Then different doses of X-ray were applied to these plates. After 
irradiation, cells were incubated in incubator at  37 , 5% CO2, 95% Air for 16 days to form 
colonies. The colonies were then washed by PBS, stained by the mixture of crystal violet and 
glutaraldehyde for half an hour. Finally, the plates were washed by tap water, and the 
colonies were counted  by naked eyes.  
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Figure 5-1. The flow chart of the clonogenic assay. Cancer cells were harvested and trypsinized to 
signal cell suspension. Then the density of the cell suspension was measured by a hemocytometer. 
Different numbers of cells were seeded in 6-well plates depend on the treatments. FMD compoumd 
was added 8 hours prior to radiation. Hypoxic condition was achieved by sealing the plates in our 
hypoxic environment system. The colonies were stained and counted after 16 days’ post-irradiate 
incubation. 
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Seed Cell Number 0Gy 2.5Gy 5Gy 7.5Gy 10Gy 
0 µM -N2 100 400 400 1000 4000  
20 µM -N2 100 400 600 1500 6000  
40 µM -N2 100 400 600 1500 6000 
0 µM -Air 100 500 750 1500 6000  
20 µM -Air 100 500 1000 2000 6000 
40 µM -Air 100 500 1000 2000 6000 
 
Table 5-1. The number of seeded A549 human lung cancer cells in the clonogenic assay. 
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5.3 Result 
 
In order to determine if the FMD compound can improve the effect of radiation therapy by 
decreasing the cancer cells’ survival, human lung cancer cells (A549) were seeded in 6-well 
plates, treated with 0/20/40 µM of the FMD compound with 0-10 Gy of X-ray under 
normoxia/hypoxia conditions. As the result shown in Figure 5-2, the survival rate of the 
cancer cells is decreasing with the X-ray dose increasing. In the presence of FMD compound, 
the cell killing was enhanced both in normoxia and hypoxia conditions. This result is 
consistent with our previous DNA damage measurements and apoptosis measurements. For 
the control groups, the oxygen enhancement effect can also be observed from Figure 5-2, this 
is a justification for our hypoxic environment system’s validation.  
 
To compare the radiosensitivities of the FMD compound under hypoxic environment and 
normoxic environment, the radio enhancement ratio (ER) of the FMD compound for both of 
these two situations were calculated. The ER is defined as the ratio of the radiation dose 
required to achieve a certain survival rate over that in the presence of radiosensitizer (see Eq. 
5-1). As shown in Figure 5-3, at 20% survival rate, the ER for hypoxic cell was 1.420.05, 
the ER for the normoxic cell was 1.100.05. The radiosensitizing effect of the FMD 
compound in hypoxic environment was predominantly enhanced. 
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Eq. 5-1 
 
 
 
 
Figure 5-2.  In vitro clonogenic assay of the radiosensitizing effects of the FMD compound tested in 
human lung cancer cells (A549). The blue dashed lines are the survival curves for the cancer cells, 
which were in hypoxic environment during IR; the red solid lines are the survival curves for the 
cancer cells which were in normoxic environment during IR.  
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Figure 5-3. In vitro clonogenic assay of the radiosensitizing effects of the FMD compound tested in human lung cancer cells (A549). The left 
panel shows the survival rates of cancer cells irradiated under normoxia condition, the right panel shows the survival rates of cancer cells 
irradiated under hypoxia conditions. The radio enhancement ratio (ER) for the right panel is significantly greater than that in the left panel.  
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5.4 Conclusion 
 
In this experiment, the radiosensitivity of the FMD compound was tested in human lung 
cancer cells (A549). The survival curves were reduced in the presence of FMD compound 
combined with radiation, the results confirmed that the FMD compound has radiosensitivity 
both in the normoxic and hypoxic environment.   
 
By comparing the radio enhancement ratios in both of these two conditions, it can be found 
that the radiosensitivity of the FMD compound was significantly enhanced in the hypoxic 
environment. These results are consistent with the observation from the in vitro DNA DSBs 
experiments and the in vitro apoptosis experiments. We therefore conclude that in the 
absence of oxygen molecules, more FMD molecules will be activated by epre−, and the 
activated FMD radical fragments are efficient in producing DNA DSBs and therefore 
apoptosis will be enhanced. This may directly lead to the decline of cancer cells’ survival 
rates. In the presence of molecular oxygen, the formation of O2• −, will partially hamper the 
effectiveness of the FMD compound and therefore, the radiosensitivity of the FMD 
compound in normoxic cells will be limited. The enhancement ratio of the FMD compound 
in hypoxic environment is 1.420.05, which is noticeably larger than the enhancement ratio 
in normoxic environment (1.100.05). These results suggest that the FMD compound has 
unique features that can be selectively activated in the hypoxic environment, and has 
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promising potential to be applied clinically to overcome the hypoxia-mediated 
radioresistance of a variety of cancer cells.  
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Chapter 6 Summary 
 
In summary, by conducting various in vitro experiments, we have demonstrated that FMD 
compound is an effective radiosensitizer on hypoxic human cancer cell lines. The 
radiosensitizing effect could be enhanced by the presence of hypoxia in the 
microenvironment of tumor. The experiment also demonstrates that the limited 
radiosensitivity of the FMD compound in the normoxic environment/tissue was a 
consequence of deficient pre-solvated electrons to activate the FMD. Our results have 
revealed a mechanism explaining the radiosensitizing effect of a variety of pre-solvated 
electron activated radiosensitizers that are effective in the hypoxic tumor environment.  
 
The in vitro steady-state absorption spectra analyses have shown that there exists a 
competition binding of pre-solvated electrons between oxygen and FMD molecules. The in 
vitro DNA DSBs detection experiment further indicates that in the absence of oxygen, the 
pre-hydrated electrons produced by ionizing radiation (IR) of water, attach to our FMD 
molecules and initiate a series of dissociative electron transfer (DET) reactions, thus induce 
severe DNA damage, especially double strand breaks. Meanwhile, under normoxia 
circumstance, oxygen molecules preferentially capture pre-solvated electrons to form 
superoxide radicals, which are relatively moderate and less destructive comparing with 
radicals formed from the dissociation of FMD molecules. Consequently, in the presence of 
oxygen, DNA is partially detoxified by the FMD compound during IR. The in vitro hypoxia-
activated radiosensitivity of the FMD compound has been evaluated through 
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immunofluorescence and clonogenic assays. The results have confirmed that the FMD 
compound can decrease the cancer cells’ survival rate and increase the number of apoptotic 
cells predominately in hypoxic environment.  
 
These findings have provided a new understanding of the mechanism of the FMD compound 
acting as a hypoxia-activated radiosensitizer and have highlighted a potential application of 
our FMD agent in natural targeted radiotherapies.  The results might be helpful to exploit 
pre-solvated electrons for novel cancer therapies. 
 
 
 
 
 
 
 65 
References 
 
[1] R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA. Cancer J. Clin., 
vol. 66, no. 1, pp. 7–30, 2016. 
[2] W. H. Organization, “GLOBOCAN 2012: Estimated cancer incidence, mortality and 
prevalence worldwide in 2012,” Lyon, Fr. Int. Agency Res. Cancer, 2014. 
[3] D. Carter, “New global survey shows an increasing cancer burden.,” Am. J. Nurs., vol. 
114, no. 3, p. 17, 2014. 
[4] A. Mullard, “2014 FDA drug approvals,” Nat. Rev. Drug Discov., vol. 14, no. 2, pp. 
77–81, 2015. 
[5] B. D. Buffery, “Innovation tops current trends in the 2016 oncology drug pipeline,” 
Am. Heal. drug benefits, vol. 9, no. 4, pp. 233–238, 2016. 
[6] D. Buffery, “The 2015 oncology drug pipeline: innovation drives the race to cure 
cancer,” Am. Heal. drug benefits, vol. 8, no. 4, p. 216, 2015. 
[7] B. Hughes, “2009 FDA drug approvals.,” Nat. Rev. Drug Discov., vol. 9, pp. 89–92, 
2010. 
[8] A. Mullard, “2013 FDA drug approvals.,” Nat. Rev. Drug Discov., vol. 13, pp. 85–89, 
2014. 
[9] S. Mailankody and V. Prasad, “Five years of cancer drug approvals: innovation, 
efficacy, and costs,” JAMA Oncol., vol. 1, no. 4, pp. 539–540, 2015. 
[10] M. O’Dell and M. Stubblefield, Cancer Rehabilitation: Principles and Practice. 2009. 
[11] J. B. Gibbs, “Mechanism-Based Target Identification and Drug Discovery in Cancer 
Research,” Science (80-. )., vol. 287, no. 5460, pp. 1969–1973, 2000. 
[12] J. Walter, Cancer and radiotherapy: a short guide for nurses and medical students. 
Churchill Livingstone, 1977. 
 66 
[13] C. Von Sonntag, The chemical basis of radiation biology. Taylor & Francis London, 
1987. 
[14] T. Ito, “Dependence of the Yield of Strand Breaks Induced by γ-rays in DNA on the 
Physical Conditions of Exposure: Water Content and Temperature,” Int. J. Radiat. 
Biol., vol. 63, no. 3, 1993. 
[15] G. C. Barnett, C. M. L. West, A. M. Dunning, R. M. Elliott, C. E. Coles, P. D. P. 
Pharoah, and N. G. Burnet, “Normal tissue reactions to radiotherapy: towards tailoring 
treatment dose by genotype,” Nat. Rev. Cancer, vol. 9, no. 2, pp. 134–142, 2009. 
[16] C.-R. Wang, J. Mahmood, Q.-R. Zhang, A. Vedadi, J. Warrington, N. Ou, R. G. 
Bristow, D. A. Jaffray, and Q.-B. Lu, “In Vitro and In Vivo Studies of a New Class of 
Anticancer Molecules for Targeted Radiotherapy of Cancer,” Mol. Cancer Ther., vol. 
15, no. 4, pp. 640–650, 2016. 
[17] H. Lodish, D. Baltimore, A. Berk, S. L. Zipursky, P. Matsudaira, and J. Darnell, 
Molecular cell biology, vol. 3. Scientific American Books New York, 1995. 
[18] R. J. Woods and A. K. Pikaev, Applied radiation chemistry: radiation processing. 
John Wiley & Sons, 1994. 
[19] S. Le Caër, “Water radiolysis: influence of oxide surfaces on H2 production under 
ionizing radiation,” Water, vol. 3, no. 1, pp. 235–253, 2011. 
[20] C. M. Lousada, I. L. Soroka, Y. Yagodzinskyy, N. V Tarakina, O. Todoshchenko, H. 
Hänninen, P. A. Korzhavyi, and M. Jonsson, “Gamma radiation induces hydrogen 
absorption by copper in water,” Sci. Rep., vol. 6, 2016. 
[21] Q.-B. Lu, “Effects and applications of ultrashort-lived prehydrated electrons in 
radiation biology and radiotherapy of cancer,” Mutat. Res. Mutat. Res., vol. 704, no. 1, 
pp. 190–199, 2010. 
[22] J. F. Wishart 1958- and D. G. Nocera 1957-, Eds., Photochemistry and radiation 
chemistry complementary methods for the study of electron transfer. Washington, DC: 
American Chemical Society, 1998. 
 67 
[23] J. A. LaVerne and R. H. Schuler, “Decomposition of water by very high linear energy 
transfer radiations,” J. Phys. Chem., vol. 87, no. 23, pp. 4564–4565, 1983. 
[24] T. Luo, J. Yu, J. Nguyen, C.-R. Wang, R. G. Bristow, D. A. Jaffray, X. Z. Zhou, K. P. 
Lu, and Q.-B. Lu, “Electron transfer-based combination therapy of cisplatin with 
tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers,” Proc. Natl. 
Acad. Sci., vol. 109, no. 26, pp. 10175–10180, 2012. 
[25] J. Nguyen, Y. Ma, T. Luo, R. G. Bristow, D. A. Jaffray, and Q.-B. Lu, “Direct 
observation of ultrafast-electron-transfer reactions unravels high effectiveness of 
reductive DNA damage,” Proc. Natl. Acad. Sci., vol. 108, no. 29, pp. 11778–11783, 
2011. 
[26] C.-R. Wang, T. Luo, and Q.-B. Lu, “On the lifetimes and physical nature of 
incompletely relaxed electrons in liquid water,” Phys. Chem. Chem. Phys., vol. 10, no. 
30, pp. 4463–4470, 2008. 
[27] J. W. Boag and E. J. Hart, “ABSORPTION SPECTRA IN IRRADIATED WATER 
AND SOME SOLUTIONS. PART I. ABSORPTION SPECTRA 
OF’HYDRATED'ELECTRON,” Nature, vol. 197, 1963. 
[28] J. M. Wiesenfeld and E. P. Ippen, “Dynamics of electron solvation in liquid water,” 
Chem. Phys. Lett., vol. 73, no. 1, pp. 47–50, 1980. 
[29] W. J. Chase and J. W. Hunt, “Solvation time of the electron in polar liquids. Water and 
alcohols,” J. Phys. Chem., vol. 79, no. 26, pp. 2835–2845, 1975. 
[30] D. P. Millar, R. Shah, and A. H. Zewail, “Picosecond saturation spectroscopy of cresyl 
violet: rotational diffusion by a ‘sticking’ boundary condition in the liquid phase,” 
Chem. Phys. Lett., vol. 66, no. 3, pp. 435–440, 1979. 
[31] N. F. Scherer, J. L. Knee, D. D. Smith, and A. H. Zewail, “Femtosecond 
photofragment spectroscopy of the reaction iodine cyanide (ICN). fwdarw. cyanogen 
(CN)+ atomic iodine,” J. Phys. Chem., vol. 89, no. 24, pp. 5141–5143, 1985. 
[32] A. Migus, Y. Gauduel, J. L. Martin, and A. Antonetti, “Excess electrons in liquid 
 68 
water: first evidence of a prehydrated state with femtosecond lifetime,” Phys. Rev. 
Lett., vol. 58, no. 15, p. 1559, 1987. 
[33] D. W. Siemann, “The unique characteristics of tumor vasculature and preclinical 
evidence for its selective disruption by Tumor-Vascular Disrupting Agents,” Cancer 
Treat. Rev., vol. 37, no. 1, pp. 63–74, 2011. 
[34] M. A. Konerding, E. Fait, and A. Gaumann, “3D microvascular architecture of pre-
cancerous lesions and invasive carcinomas of the colon,” Br. J. Cancer, vol. 84, no. 10, 
p. 1354, 2001. 
[35] T. P. Padera, A. Kadambi, E. di Tomaso, C. M. Carreira, E. B. Brown, Y. Boucher, N. 
C. Choi, D. Mathisen, J. Wain, and E. J. Mark, “Lymphatic metastasis in the absence 
of functional intratumor lymphatics,” Science (80-. )., vol. 296, no. 5574, pp. 1883–
1886, 2002. 
[36] C. Riva, C. Chauvin, C. Pison, and X. Leverve, “Cellular physiology and molecular 
events in hypoxia-induced apoptosis.,” Anticancer Res., vol. 18, no. 6B, pp. 4729–
4736, 1997. 
[37] R. H. Thomlinson and L. H. Gray, “The histological structure of some human lung 
cancers and the possible implications for radiotherapy,” Br. J. Cancer, vol. 9, no. 4, p. 
539, 1955. 
[38] T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. 
J. Giaccia, “Hypoxia-mediated selection of cells with diminished apoptotic potential in 
solid tumours,” Nature, vol. 379, no. 6560, pp. 88–91, 1996. 
[39] C. Y. Kim, M. H. Tsai, C. Osmanian, T. G. Graeber, J. E. Lee, R. G. Giffard, J. A. 
DiPaolo, D. M. Peehl, and A. J. Giaccia, “Selection of human cervical epithelial cells 
that possess reduced apoptotic potential to low-oxygen conditions,” Cancer Res., vol. 
57, no. 19, pp. 4200–4204, 1997. 
[40] G. L. Wang, B.-H. Jiang, E. A. Rue, and G. L. Semenza, “Hypoxia-inducible factor 1 
is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension,” Proc. 
 69 
Natl. Acad. Sci., vol. 92, no. 12, pp. 5510–5514, 1995. 
[41] T. Y. Reynolds, S. Rockwell, and P. M. Glazer, “Genetic instability induced by the 
tumor microenvironment,” Cancer Res., vol. 56, no. 24, pp. 5754–5757, 1996. 
[42] J. B. Mitchell, S. McPherson, W. DeGraff, J. Gamson, A. Zabell, and A. Russo, 
“Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of 
Chinese hamster cells,” Cancer Res., vol. 45, no. 5, pp. 2008–2011, 1985. 
[43] E. J. Hall and A. J. Giaccia, “The oxygen effect and reoxygenation,” Radiobiol. 
Radiol., vol. 6, pp. 85–105, 1994. 
[44] I. Tannock and R. P. Hill  1942-, Eds., The Basic science of oncology, 2nd ed. CN. 
New York: McGraw-Hill, Health Professions Division, 1992. 
[45] J. K. Mohindra and A. M. Rauth, “Increased cell killing by metronidazole and 
nitrofurazone of hypoxic compared to aerobic mammalian cells,” Cancer Res., vol. 36, 
no. 3, pp. 930–936, 1976. 
[46] D. J. Chaplin, M. R. Horsman, M. J. Trotter, and D. W. Siemann, “Therapeutic 
significance of microenvironmental factors,” Blood Perfus. Microenviron. Hum. 
Tumors, pp. 131–143, 1998. 
[47] M. Höckel and P. Vaupel, “Tumor hypoxia: definitions and current clinical, biologic, 
and molecular aspects,” J. Natl. Cancer Inst., vol. 93, no. 4, pp. 266–276, 2001. 
[48] M. S. Soengas, R. M. Alarcon, H. Yoshida, R. Hakem, T. W. Mak, and S. W. Lowe, 
“Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition,” Science (80-
. )., vol. 284, no. 5411, pp. 156–159, 1999. 
[49] C. V Dang and G. L. Semenza, “Oncogenic alterations of metabolism,” Trends 
Biochem. Sci., vol. 24, no. 2, pp. 68–72, 1999. 
[50] B. A. Teicher, S. A. Holden, A. Al-Achi, and T. S. Herman, “Classification of 
antineoplastic treatments by their differential toxicity toward putative oxygenated and 
hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma,” Cancer 
 70 
Res., vol. 50, no. 11, pp. 3339–3344, 1990. 
[51] B. A. Teicher, J. S. Lazo, and A. C. Sartorelli, “Classification of antineoplastic agents 
by their selective toxicities toward oxygenated and hypoxic tumor cells,” Cancer Res., 
vol. 41, no. 1, pp. 73–81, 1981. 
[52] S. Koch, F. Mayer, F. Honecker, M. Schittenhelm, and C. Bokemeyer, “Efficacy of 
cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic 
and hypoxic conditions in vitro,” Br. J. Cancer, vol. 89, no. 11, pp. 2133–2139, 2003. 
[53] L. H. Gray, A. Conger, M. Ebert, S. Hornsey, and O. C. A. Scott, “The concentration 
of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy,” Br. 
J. Radiol., vol. 26, no. 312, pp. 638–648, 1953. 
[54] D. Ewing, “The oxygen fixation hypothesis: a reevaluation,” Am. J. Clin. Oncol., vol. 
21, no. 4, pp. 355–361, 1998. 
[55] H. Ahsan, A. Ali, and R. Ali, “Oxygen free radicals and systemic autoimmunity,” Clin. 
Exp. Immunol., vol. 131, no. 3, pp. 398–404, 2003. 
[56] D. R. Grimes and M. Partridge, “A mechanistic investigation of the oxygen fixation 
hypothesis and oxygen enhancement ratio,” Biomed. Phys. Eng. express, vol. 1, no. 4, 
p. 45209, 2015. 
[57] M. Valko, M. Izakovic, M. Mazur, C. J. Rhodes, and J. Telser, “Role of oxygen 
radicals in DNA damage and cancer incidence,” Mol. Cell. Biochem., vol. 266, no. 1–2, 
pp. 37–56, 2004. 
[58] K. J. A. Davies, “Protein modification by oxidants and the role of proteolytic enzymes,” 
Biochem. Soc. Trans., vol. 21, no. 2, pp. 346–353, 1993. 
[59] T. Lindahl, “Instability and decay of the primary structure of DNA,” Nature, vol. 362, 
no. 6422, pp. 709–715, 1993. 
[60] B. Haliwell, “Free radicals antioxidants and human disease: curiosity, cause or 
consequence,” Lancet, vol. 344, no. 7, pp. 21–724, 1994. 
 71 
[61] D. Dreher and A. F. Junod, “Role of oxygen free radicals in cancer development,” Eur. 
J. Cancer, vol. 32, no. 1, pp. 30–38, 1996. 
[62] P. S. Brookes, A.-L. Levonen, S. Shiva, P. Sarti, and V. M. Darley-Usmar, 
“Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen 
species 1, 2,” Free Radic. Biol. Med., vol. 33, no. 6, pp. 755–764, 2002. 
[63] B. A. Freeman and J. D. Crapo, “Biology of disease: free radicals and tissue injury.,” 
Lab. Invest., vol. 47, no. 5, pp. 412–426, 1982. 
[64] L. Y. Lu, N. Ou, and Q.-B. Lu, “Antioxidant induces DNA damage, cell death and 
mutagenicity in human lung and skin normal cells,” Sci. Rep., vol. 3, 2013. 
[65] Y. Liu, G. Fiskum, and D. Schubert, “Generation of reactive oxygen species by the 
mitochondrial electron transport chain,” J. Neurochem., vol. 80, no. 5, pp. 780–787, 
2002. 
[66] T.-T. Huang, Y. Zou, and R. Corniola, “Oxidative stress and adult neurogenesis—
effects of radiation and superoxide dismutase deficiency,” in Seminars in cell & 
developmental biology, 2012, vol. 23, no. 7, pp. 738–744. 
[67] W. A. Pryor, “Oxy-radicals and related species: their formation, lifetimes, and 
reactions,” Annu. Rev. Physiol., vol. 48, no. 1, pp. 657–667, 1986. 
[68] I. Fridovich, “Superoxide anion radical (O· 2), superoxide dismutases, and related 
matters,” J. Biol. Chem., vol. 272, no. 30, pp. 18515–18517, 1997. 
[69] Q.-B. Lu, Q.-R. Zhang, N. Ou, C.-R. Wang, and J. Warrington, “In vitro and in vivo 
studies of non-platinum-based halogenated compounds as potent antitumor agents for 
natural targeted chemotherapy of cancers,” EBioMedicine, vol. 2, no. 6, pp. 544–553, 
2015. 
[70] Q.-B. Lu, New theories and predictions on the ozone hole and climate change. World 
Scientific, 2015. 
[71] P. A. Jeggo and M. Löbrich, “How cancer cells hijack DNA double-strand break 
 72 
repair pathways to gain genomic instability,” Biochem. J., vol. 471, no. 1, pp. 1–11, 
2015. 
[72] O. V Belov, E. A. Krasavin, M. S. Lyashko, M. Batmunkh, and N. H. Sweilam, “A 
quantitative model of the major pathways for radiation-induced DNA double-strand 
break repair,” J. Theor. Biol., vol. 366, pp. 115–130, 2015. 
[73] C. Negritto, “Repairing double-strand DNA breaks,” Nat. Educ., vol. 3, no. 9, p. 26, 
2010. 
[74] T. K. Kelly, T. B. Miranda, G. Liang, B. P. Berman, J. C. Lin, A. Tanay, and P. A. 
Jones, “H2A. Z maintenance during mitosis reveals nucleosome shifting on mitotically 
silenced genes,” Mol. Cell, vol. 39, no. 6, pp. 901–911, 2010. 
[75] A. Dupré, L. Boyer-Chatenet, and J. Gautier, “Two-step activation of ATM by DNA 
and the Mre11–Rad50–Nbs1 complex,” Nat. Struct. Mol. Biol., vol. 13, no. 5, pp. 451–
457, 2006. 
[76] O. A. Sedelnikova, E. P. Rogakou, I. G. Panyutin, and W. M. Bonner, “Quantitative 
detection of 125IdU-induced DNA double-strand breaks with γ-H2AX antibody,” 
Radiat. Res., vol. 158, no. 4, pp. 486–492, 2002. 
[77] M. Podhorecka, A. Skladanowski, and P. Bozko, “H2AX phosphorylation: its role in 
DNA damage response and cancer therapy,” J. Nucleic Acids, vol. 2010, 2010. 
[78] L. J. Kuo and L.-X. Yang, “γ-H2AX-a novel biomarker for DNA double-strand 
breaks,” In Vivo (Brooklyn)., vol. 22, no. 3, pp. 305–309, 2008. 
[79] R. Wang, F. Jin, and H. Zhong, “A novel experimental hypoxia chamber for cell 
culture,” Am. J. Cancer Res., vol. 4, no. 1, p. 53, 2014. 
[80] S. M. Bakmiwewa, B. Heng, G. J. Guillemin, H. J. Ball, and N. H. Hunt, “An effective, 
low-cost method for achieving and maintaining hypoxia during cell culture studies,” 
Biotechniques, vol. 59, no. 4, pp. 223–229, 2015. 
[81] R. E. Ellis, J. Yuan, and H. R. Horvitz, “Mechanisms and functions of cell death,” 
 73 
Annu. Rev. Cell Biol., vol. 7, no. 1, pp. 663–698, 1991. 
[82] H. Steller, “Mechanisms and genes of cellular suicide,” Science (80-. )., vol. 267, no. 
5203, p. 1445, 1995. 
[83] S. Nagata, “Apoptosis by death factor,” Cell, vol. 88, no. 3, pp. 355–365, 1997. 
[84] S. Rathore, G. Datta, I. Kaur, P. Malhotra, and A. Mohmmed, “Disruption of cellular 
homeostasis induces organelle stress and triggers apoptosis like cell-death pathways in 
malaria parasite,” Cell Death Dis., vol. 6, no. 7, p. e1803, 2015. 
[85] S. W. Lowe and A. W. Lin, “Apoptosis in cancer,” Carcinogenesis, vol. 21, no. 3, pp. 
485–495, 2000. 
[86] C. Stadelmann, T. L. Deckwerth, A. Srinivasan, C. Bancher, W. Brück, K. Jellinger, 
and H. Lassmann, “Activation of caspase-3 in single neurons and autophagic granules 
of granulovacuolar degeneration in Alzheimer’s disease: evidence for apoptotic cell 
death,” Am. J. Pathol., vol. 155, no. 5, pp. 1459–1466, 1999. 
[87] M. E. Guicciardi and G. J. Gores, “Life and death by death receptors,” FASEB J., vol. 
23, no. 6, pp. 1625–1637, 2009. 
[88] N. Özören and W. S. El-Deiry, “Cell surface death receptor signaling in normal and 
cancer cells,” in Seminars in cancer biology, 2003, vol. 13, no. 2, pp. 135–147. 
[89] S. Kothakota, T. Azuma, C. Reinhard, A. Klippel, J. Tang, K. Chu, T. J. McGarry, M. 
W. Kirschner, K. Koths, and D. J. Kwiatkowski, “Caspase-3-generated fragment of 
gelsolin: effector of morphological change in apoptosis,” Science (80-. )., vol. 278, no. 
5336, pp. 294–298, 1997. 
[90] K. Buch, T. Peters, T. Nawroth, M. Sänger, H. Schmidberger, and P. Langguth, 
“Determination of cell survival after irradiation via clonogenic assay versus multiple 
MTT Assay-A comparative study,” Radiat. Oncol., vol. 7, no. 1, p. 1, 2012. 
[91] N. A. P. Franken, H. M. Rodermond, J. Stap, J. Haveman, and C. Van Bree, 
“Clonogenic assay of cells in vitro,” Nat. Protoc., vol. 1, no. 5, pp. 2315–2319, 2006. 
 74 
[92] J. C. Stockert, A. Blázquez-Castro, M. Cañete, R. W. Horobin, and Á. Villanueva, 
“MTT assay for cell viability: Intracellular localization of the formazan product is in 
lipid droplets,” Acta Histochem., vol. 114, no. 8, pp. 785–796, 2012. 
 
